Circulogene Theranostics, Inc.
BIRMINGHAM, AL · Founded 2015 · CIK 0001646728 · Medtech · Private
Comprehensive genomic profiling tests and molecular diagnostic assays for solid tumor classification and monitoring
circulogene.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $9.1M
- 10 Form D · Mar 2023
- 42 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,230,000 | |
| Private capital raised | Form D · SEC | $750,000 | |
| Private capital raised | Form D · SEC | $355,000 | |
| Private capital raised | Form D · SEC | $350,000 | |
| Private capital raised | Form D · SEC | $1,035,000 | |
| Private capital raised | Form D · SEC | $2,050,000 | |
| Private capital raised | Form D · SEC | $330,000 | |
| Private capital raised | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $750,000 | |
| Private capital raised | Form D · SEC | $2,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1069 | Valencia Technologies Corp | — | $20M |
| 1070 | Best Tech Brands, LLC | — | $311K |
| 1071 | METRIA INNOVATION, INC. | — | — |
| 1072 | Circulogene Theranostics, Inc. | — | $9.1M |
| 1073 | Pepex Biomedical, Inc. | — | $202K |
| 1074 | Paradromics, Inc. | — | $55M |
| 1075 | ResQ Pharma, Inc. | — | $2.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Richard BrandExecutive Officer
- James CantrellDirector
- Charles ClarkDirector
- Daniel ColemanDirector
- Harold DunnDirector
- Stephen EckDirector
- Edwin FinchDirector
- Robert GarvieDirector
- Michael MullenDirector · Executive Officer
- Mike MullenDirector · Executive Officer · Promoter
- Charles MusialExecutive Officer
- Scott RezekExecutive Officer
- Thomas SatterfieldDirector
- Chen YehExecutive Officer
- Chen-Hsiung YehExecutive Officer
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.